Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crocin in Central Serous Chorioretinopathy
NCT04936490Phase 1Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetaminophen in Central Serous Chorioretinopathy (CSCR), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Best-corrected visual acuity at 8 weeks. Status: unknown.
02
Drugs
acetaminophen
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT04936490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04936490.